AngioDynamics (NASDAQ:ANGO) Issues FY25 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of ($0.42)-($0.38) for the period, compared to the consensus EPS estimate of ($0.41). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $284.37 million. AngioDynamics also updated its FY 2025 guidance […]
More Stories
Port Strike Ends as Union Reaches Tentative Agreement
By Andrew Moran Tens of thousands of dock and port workers are heading back to work after their union and...
EVgo (NYSE:EVGO) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of EVgo (NYSE:EVGO – Free Report) in a report released on Monday...
Paychex (NASDAQ:PAYX) Issues Quarterly Earnings Results, Beats Estimates By $0.02 EPS
Paychex (NASDAQ:PAYX – Get Free Report) issued its quarterly earnings results on Tuesday. The business services provider reported $1.16 EPS...
CDC Issues Warning on Overdose Risk From Fake Prescription Medicines Online
By Jack Phillips The U.S. Centers for Disease Control and Prevention (CDC) this week warned Americans of a potential overdose...
AbbVie (NYSE:ABBV) Updates Q3 2024 Earnings Guidance
AbbVie (NYSE:ABBV – Get Free Report) updated its third quarter 2024 earnings guidance on Thursday. The company provided EPS guidance...
Nobody Wants This Season 2: Cast, and Release Date Speculation
Fans of the recently released Netflix original series Nobody Wants This are already wondering when Season 2 will be available....